Pakistan frets about production plants' futures; India plans spurious drug clampdown;

> The Pakistani drug industry fears government missteps will lead to plant closures. News

> Indian officials have detailed plans to tackle substandard and counterfeit drugs. Article

> JHL Biotech is using GE's FlexFactory biomanufacturing platform at its Taiwan production plant. Release

> A reactor blast at an Indian pharma ingredient facility has injured two people. Article

> Granules India is looking to expand its production capabilities through acquisition. Piece

> Latvia-based Grindeks is investing in a new quality control laboratory. Item (sub. req.)

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.